TY - JOUR
T1 - The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults
T2 - Histopathological evaluation of a series
AU - Ginsberg, Lawrence E.
AU - Fuller, Gregory N.
AU - Hashmi, Masood
AU - Leeds, Norman E.
AU - Schomer, Donald F.
PY - 1998/4
Y1 - 1998/4
N2 - BACKGROUND: To correlate magnetic resonance imaging (MRI) findings of non-enhancement of supratentorial brain neoplasms in adults with histopathologic findings. METHODS: Forty adult patients whose preoperative MRI studies demonstrated a non-enhancing supratentorial brain neoplasm were identified retrospectively. Biopsy material for all patients was then reviewed by a board-certified neuropathologist. RESULTS: Histopathologic examination identified 24 (60%) low-grade gliomas: 4 (10%) low-grade astrocytomas, 10 (25%) low-grade gliomas (not further classified), 8 (20%) low-grade oligodendrogliomas, and 2 (5%) low-grade mixed oligoastrocytomas. However, 16 (40%) nonenhancing lesions were classified as anaplastic gliomas: 12 (30%) anaplastic astrocytomas, 1 (2.5%) anaplastic mixed oligoastrocytoma, 1 (2.5%) anaplastic oligodendroglioma, and 2 (5%) anaplastic infiltrating gliomas of indeterminate subtype. CONCLUSION: Non-enhancement of supratentorial brain neoplasms in adults does not equate with low-grade malignancy. This fact should be taken into account when biopsy and treatment are being planned in patients with nonenhancing brain tumors. More aggressive and/or surgical therapy might be indicated for such lesions, particularly those in the nondominant hemisphere or nonmotor areas.
AB - BACKGROUND: To correlate magnetic resonance imaging (MRI) findings of non-enhancement of supratentorial brain neoplasms in adults with histopathologic findings. METHODS: Forty adult patients whose preoperative MRI studies demonstrated a non-enhancing supratentorial brain neoplasm were identified retrospectively. Biopsy material for all patients was then reviewed by a board-certified neuropathologist. RESULTS: Histopathologic examination identified 24 (60%) low-grade gliomas: 4 (10%) low-grade astrocytomas, 10 (25%) low-grade gliomas (not further classified), 8 (20%) low-grade oligodendrogliomas, and 2 (5%) low-grade mixed oligoastrocytomas. However, 16 (40%) nonenhancing lesions were classified as anaplastic gliomas: 12 (30%) anaplastic astrocytomas, 1 (2.5%) anaplastic mixed oligoastrocytoma, 1 (2.5%) anaplastic oligodendroglioma, and 2 (5%) anaplastic infiltrating gliomas of indeterminate subtype. CONCLUSION: Non-enhancement of supratentorial brain neoplasms in adults does not equate with low-grade malignancy. This fact should be taken into account when biopsy and treatment are being planned in patients with nonenhancing brain tumors. More aggressive and/or surgical therapy might be indicated for such lesions, particularly those in the nondominant hemisphere or nonmotor areas.
KW - Brain tumors
KW - Contrast enhancement
KW - Magnetic resonance imaging
UR - http://www.scopus.com/inward/record.url?scp=0032054259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032054259&partnerID=8YFLogxK
U2 - 10.1016/S0090-3019(97)00360-1
DO - 10.1016/S0090-3019(97)00360-1
M3 - Article
C2 - 9537664
AN - SCOPUS:0032054259
SN - 0090-3019
VL - 49
SP - 436
EP - 440
JO - Surgical Neurology
JF - Surgical Neurology
IS - 4
ER -